What is Ocular Therapeutix's operating lease liabilities?

Ocular Therapeutix (OCUL) reported operating lease liabilities of $1.77M in Q1 2026.

How has Ocular Therapeutix's operating lease liabilities changed year-over-year?

Ocular Therapeutix's operating lease liabilities increased by 790.6% year-over-year, from -$256K to $1.77M.

What is the long-term trend for Ocular Therapeutix's operating lease liabilities?

Over 4 years (2021 to 2025), Ocular Therapeutix's operating lease liabilities has grown at a 5.1% compound annual growth rate (CAGR), from -$1.36M to -$1.66M.

Ocular Therapeutix OCUL Operating lease liabilities

Operating lease liabilities at other companies

Kodiak Sciences IncKOD

——

Axsome TherapeuticsAXSM

——

TG TherapeuticsTGTX

——

Pulse Biosciences, Inc.PLSE

——

PVL

Palvella TherapeuticsPVLA

——

Xenon PharmaceuticalsXENE

——

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.16B+58.2%

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's operating lease liabilities?: Ocular Therapeutix (OCUL) reported operating lease liabilities of $1.77M in Q1 2026.
How has Ocular Therapeutix's operating lease liabilities changed year-over-year?: Ocular Therapeutix's operating lease liabilities increased by 790.6% year-over-year, from -$256K to $1.77M.
What is the long-term trend for Ocular Therapeutix's operating lease liabilities?: Over 4 years (2021 to 2025), Ocular Therapeutix's operating lease liabilities has grown at a 5.1% compound annual growth rate (CAGR), from -$1.36M to -$1.66M.